Acutaas Chemicals Limited (BOM:543349)

Market Cap	89.77B
Revenue (ttm)	10.07B
Net Income (ttm)	1.59B
Shares Out	n/a
EPS (ttm)	19.81
PE Ratio	56.56
Forward PE	40.06
Dividend	1.50 (0.13%)
Ex-Dividend Date	Sep 13, 2024

Volume	5,161
Average Volume	17,825
Open	1,104.70
Previous Close	1,104.15
Day's Range	1,075.95 - 1,109.00
52-Week Range	600.00 - 1,321.75
Beta	n/a
RSI	40.16
Earnings Date	Jul 28, 2025

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formul...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 676
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.